SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________________________________________________________________

FORM 6-K

____________________________________________________________________________

REPORT OF FOREIGN ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

June 45, 2025

____________________________________________________________________________

KONINKLIJKE PHILIPS N.V.

(Exact name of registrant as specified in its charter)

____________________________________________________________________________

Royal Philips

(Translation of registrant’s name into English)

The Netherlands

(Jurisdiction of incorporation or organization)

Prinses Irenestraat 59, 1077 WV Amsterdam, The Netherlands

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7): ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☒

Name and address of person authorized to receive notices and communications from the Securities and Exchange Commission:

M.J. van Ginneken

Koninklijke Philips N.V.

Prinses Irenestraat 59

1077 WV Amsterdam – The Netherlands

This report comprises a copy of the following report:

“Philips toannounces ~~repurchase~~exchange upratio tofor 62024 ~~million shares to cover long-term incentive plans~~dividend”, dated June 45, 2025.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, by the undersigned, thereunto duly authorized at Amsterdam, on the ~~4th~~fifth day of June 2025.

KONINKLIJKE PHILIPS N.V.

/s/ M.J. van Ginneken
(Chief Legal Officer)

Press Release

June 45, 2025

Philips toannounces ~~repurchase~~exchange upratio tofor 62024 ~~million~~dividend ~~shares to cover long-term incentive plans~~

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that itthe ~~will~~exchange ~~repurchase~~ratio upfor tothe 6dividend ~~million~~for ~~shares~~the toyear ~~cover~~2024 ~~certain~~is of1 ~~its~~new ~~obligations~~common ~~arising~~share ~~from~~for ~~its~~every ~~long-term~~23.6353 ~~incentive~~existing ~~plans~~common shares. AtThis ratio was based on the ~~current~~volume ~~share~~weighted average price on Euronext Amsterdam of May 30, ~~the~~June ~~shares~~2, ~~represent~~and an3, ~~amount~~2025, of upEUR to20.0600 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR ~~125~~0.85. ~~million~~As a result, Philips will issue a total number of 22,980,748 new common shares.

~~The~~Shareholders ~~repurchases~~have ~~will~~been begiven ~~executed~~the ~~through~~opportunity ~~one~~to ormake ~~more~~their ~~individual~~choice ~~forward~~between ~~transactions,~~a todividend ~~be entered into~~ in ~~the~~shares ~~course~~or of(subject ~~the~~to ~~second~~certain ~~and~~conditions) ~~third~~in ~~quarter~~cash. ofThe ~~2025,~~aggregate incash ~~accordance~~election ~~with~~result ~~the~~was ~~Market~~41.4%, ~~Abuse~~which ~~Regulation~~is ~~and~~below ~~within~~ the ~~limits~~50% ofmaximum ~~the~~as ~~authorization~~adopted ~~granted~~in by the ~~company’s~~ General Meeting of Shareholders onand ~~May~~therefore 8,shareholders ~~2025.~~will ~~Philips~~receive ~~expects to take delivery of~~ the ~~shares~~dividend in ~~2027.~~accordance ~~Further~~with ~~details~~their ~~will be available via this link~~election.

Delivery of new common shares, with settlement of fractions in cash, if required, and payment of the cash dividend will take place from June 6, 2025. Upon distribution, the total issued share capital will amount to EUR 192,584,026, representing 962,920,132 common shares. More information is available via this link.

For further information, please contact:

Michael Fuchs

Philips Global External Relations

Tel.: +31 6 1486 9261

E-mail: michael.fuchs@philips.com

Dorin Danu

Philips Investor Relations

Tel.: +31 20 59 77055

E-mail: dorin.danu@philips.com

About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Forward-looking statements

This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.

Filing Compare · KONINKLIJKE PHILIPS NV